Vitamin D Testing Market Size, Share, Growth, Trends, and Global Industry Analysis: By Test (25-Hydroxy D Vitamin and 1,25-Dihydroxy D Vitamin), By Technique (Radioimmunoassay, ELISA, HPLC, LC-MS, and Others), By Indication (Osteoporosis, Rickets, Thyroid Disorders, Malabsorption, Vitamin D Deficiency, and Others), By End User (Hospitals, Diagnostic Laboratories, Home Care, Point-of-care, and Others) and Region  

Vitamin D Testing Market size was value of US$ 674.5 million in 2023 and is poised to grow at a CAGR of 5.1% from 2024-2030. In both industrialized and developing nations, vitamin D insufficiency is becoming more common due to increased deskbound lifestyles and decreased sun exposure. In India, for example, the prevalence of vitamin D deficiency was close to 67.0% in 2021, and 1 billion people globally were affected by complications related to vitamin D deficiency, according to a BioMed Central Ltd. report. This is leading to an increase in demand for and adoption of the products used in vitamin D testing and is thus estimated to witness significant growth during the study period.

Further, with the clinically documented link between a number of severe and chronic diseases, viz. diabetes, cancer, autoimmune and cardiovascular diseases, and vitamin D deficiency, the market size can be anticipated to see a substantial boost. The expansion of the market is also being fueled by increasing activities to raise awareness about vitamin levels, such as vitamin D, in both developed and developing countries, as well as by new studies highlighting vitamin D's significance to one's overall health. This aspect is also helping the market's expansion internationally, along with rising investments made by leading players in R&D for new testing technologies. Several KOL studies reveal that there has been a significant increase in patient volume in 2021 compared to 2020.

Additionally, during the study period, the development of sophisticated point-of-care testing kits and raising health awareness of the post-COVID-19 situation are encouraging the adoption rate of devices, which can the projected as one of the vital fueling factors for the market growth. Additionally, the major players in the market saw a sharp rise in sales in 2021, which brought them back to their pre-pandemic levels. The above driving factor for the market analysis by PBI, also pointed out that repetitive testing has significantly increased in wealthy nations, including the United States, Germany, and others. This leads to excessive use of healthcare resources, such as test kits, reagents, and others, which over time raises the responsibilities associated with healthcare.

Additionally, the rising cost of the test is preventing the broader populace in emerging nations like Brazil, South Africa, and others from utilizing vitamin D tests (the average cost of a vitamin D test with consultation is about US$ 41.0, as per KINGS COLLEGE HOSPITAL in Dubai). These supply chain scarcities and high costs act as the main restraining factor for the market growth.  

Vitamin D Testing Market Key Developments  

• In May 2020, Abbott reported that ID NOW, a point-of-care rapid test that delivers findings in minutes as opposed to needing days or weeks, available in the United States.
• In March 2020 Thermo Fisher Scientific Inc. launched the Cascadion SM Clinical Analyzer for the Cascadion SM 25-hydroxy vitamin D assay in the United States.